Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Bone|April 26, 2011
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblastsDorit Naot, Ashika Chhana, Brya G Matthews, et al.Scientific Reports|November 11, 2020
Raman spectroscopy reveals age- and sex-related differences in cortical bone from people with osteoarthritisMichel K Nieuwoudt, Rayomand Shahlori, Dorit Naot, et al.Bone Reports|March 13, 2023
<i>FLNA-</i>filaminopathy skeletal phenotypes are not due to an osteoblast autonomous loss-of-functionEmma M Wade, Elizabeth A Goodin, Yongqiang Wang, et al.Schizophrenia Research|December 28, 2010
The atypical anti-psychotic clozapine decreases bone mass in rats in vivoJessica L Costa, Greg Smith, Maureen Watson, et al.American Journal of Physiology. Endocrinology and Metabolism|April 23, 2009
Actions of fibroblast growth factor-8 in bone cells in vitroJian-Ming Lin, Karen E Callon, Jun-Sheng Lin, et al.Bone|May 10, 2011
The skeletal effects of the tyrosine kinase inhibitor nilotinibSusannah O'Sullivan, Jian-Ming Lin, Maureen Watson, et al.Journal of Orthopaedic Surgery and Research|February 22, 2019
Bovine bone particulates containing bone anabolic factors as a potential xenogenic bone graft substituteDavid S Musson, Ryan Gao, Maureen Watson, et al.Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|October 23, 2012
Fluorosis as a probable factor in metabolic bone disease in captive New Zealand native frogs (Leiopelma species)Stephanie D Shaw, Phillip J Bishop, Catherine Harvey, et al.The FEBS Journal|July 11, 2013
Extended treatment with selective phosphatidylinositol 3-kinase and mTOR inhibitors has effects on metabolism, growth, behaviour and bone strengthGreg C Smith, Wee-Kiat Ong, Jessica L Costa, et al.Endocrinology|May 2, 2009
In vitro and in vivo effects of adiponectin on boneGarry A Williams, Yu Wang, Karen E Callon, et al.Pageof 5